As the primary objective of the ptx100 trial is safety, and upon SYC’s comment on yesterday’s presentation was that the data is at hand and analysis is underway, we can make the connection that there were no significant adverse reactions to the participants.
That said, we now await the secondary objective that of the ‘top line’ efficacy results. Of course, the full analysis can take weeks to be announced.
Luck to all that hold.
As the primary objective of the ptx100 trial is safety, and upon...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.82M | |||
| Open | High | Low | Value | Volume |
| 4.2¢ | 4.2¢ | 4.2¢ | $120 | 2.857K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 48149 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 53547 | 3 |
View Market Depth
| Last trade - 10.06am 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.1¢ |
Change
0.000 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 4.0¢ | 4.1¢ | 4.0¢ | 81081 | ||
| Last updated 11.21am 14/05/2024 ? | |||||
| PTX (ASX) Chart |